ALLMedicine™ Vasculitis Center

Sep 24th, 2020 - COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion.|2020|Vacchi C,Meschiari M,Milic J,Marietta M,Tonelli R,|

Sep 24th, 2020 - Annular leukocytoclastic vasculitis in a patient with PR3-antineutrophil cytoplasmic antibody-positive ulcerative colitis.|2020|Gambichler T,Susok L,Abu Rached N,Stücker M,Scheel C,|

Sep 23rd, 2020 - Antineutrophil cytoplasmic autoantibodies (ANCA) associated vasculitis (AAV) consists of a group of systemic autoimmune diseases. The roles of serum anti-nuclear antibodies (ANA) and anti-double-stranded DNA (anti-dsDNA) antibodies in AAV patients...

Sep 23rd, 2020 - Introduction: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare form of small-vessel vasculitis characterized by asthma, hyper-eosinophilia, and progressive multiorgan involvement. EGPA is traditionally treated using corticosteroids, ...

Sep 23rd, 2020 - PEXIVAS: The End of Plasmapheresis for ANCA-Associated Vasculitis?|2020|De Vriese AS,Fervenza FC,|

Mar 17th, 2019 - IgA vasculitis (IgAV, formerly known as Henoch-Schönlein purpura) is the most common cause of systemic vasculitis in childhood. To date, there are no internationally agreed, evidence-based guidelines concerning the appropriate diagnosis and treatm...

Oct 6th, 2017 - The proposal by the 1994 International Chapel Hill Consensus Conference on the Nomenclature of Systemic Vasculitides (CHCC1994) and by the CHCC2012 markedly influenced the classification and way of considering cutaneous vasculitis. In the proposal...

Mar 30th, 2017 - Kawasaki disease is an acute vasculitis of childhood that leads to coronary artery aneurysms in ≈25% of untreated cases. It has been reported worldwide and is the leading cause of acquired heart disease in children in developed countries. To revis...

Dec 30th, 2016 - IgA vasculitis (Henoch-Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data.|2016|Woerner A,Rudin C,Bonetto C,Santuccio C,Ozen S,|adverse effects,classification,diagnosis,immunology,...

Jun 24th, 2016 - In this article, the 2009 European League Against Rheumatism (EULAR) recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have been updated. The 2009 recommendations were on the management of...

Sep 24th, 2020 - COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion.|2020|Vacchi C,Meschiari M,Milic J,Marietta M,Tonelli R,|

Sep 24th, 2020 - Annular leukocytoclastic vasculitis in a patient with PR3-antineutrophil cytoplasmic antibody-positive ulcerative colitis.|2020|Gambichler T,Susok L,Abu Rached N,Stücker M,Scheel C,|

Sep 23rd, 2020 - Antineutrophil cytoplasmic autoantibodies (ANCA) associated vasculitis (AAV) consists of a group of systemic autoimmune diseases. The roles of serum anti-nuclear antibodies (ANA) and anti-double-stranded DNA (anti-dsDNA) antibodies in AAV patients...

Sep 23rd, 2020 - Introduction: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare form of small-vessel vasculitis characterized by asthma, hyper-eosinophilia, and progressive multiorgan involvement. EGPA is traditionally treated using corticosteroids, ...

Sep 23rd, 2020 - PEXIVAS: The End of Plasmapheresis for ANCA-Associated Vasculitis?|2020|De Vriese AS,Fervenza FC,|

Mar 5th, 2020 - IgA Vasculitis Presentation IgA vasculitis, or Henoch-Schönlein purpura, classically presents as a tetrad of palpable purpura, acute-onset arthritis or arthralgia, abdominal pain, and renal disease with proteinuria or hematuria. 30 Skin involvement.

Mar 2nd, 2020 - FILE PHOTO: The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020. REUTERS/Arnd Wiegmann ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday the safety data available for its eye dru...

Feb 11th, 2020 - A comprehensive drug history from at least 6 months prior to presentation is essential. Biopsies also are strongly encouraged to confirm the presence of vasculitis and to determine its severity.

Feb 4th, 2020 - Clinical Presentation Several clinical presentations of orthopedic IHRs have been described. Perhaps the most commonly recognized is a localized cutaneous eczematous eruption, with dermatitis typically overlying the site of the implanted material.

Jan 16th, 2020 - The rash was consistent with nonblanching purpura. Two punch biopsies were performed for hematoxylin and eosin stain and direct immunofluorescence, which were consistent with IgA mediated small vessel vasculitis, or Henoch-Schoenlein purpura.